Search research articles
Contact Us
Filters
Showing results (21-30 of 180) with videos related to
Page
of 18
Sort By:
The Journal of Clinical Endocrinology and Metabolism
|
February 7, 2001
Construction of gene therapy vectors targeting thyroid cells: enhancement of activity and specificity with histone deacetylase inhibitors and agents modulating the cyclic adenosine 3',5'-monophosphate pathway and demonstration of activity in follicular and anaplastic thyroid carcinoma cells
M Kitazono, Y Chuman, T Aikou, et al.
Current Drug Targets
|
May 12, 2004
Intractable cancers: the many faces of multidrug resistance and the many targets it presents for therapeutic attack
W D Stein, S E Bates, T Fojo
Japanese Journal of Cancer Research : Gann
|
September 27, 2001
Altered topoisomerase IIalpha and multidrug resistance-associated protein levels during drug selection: adaptations to increasing drug pressure
Y Matsumoto, H Takano, S Nagao, et al.
Leukemia & Lymphoma
|
March 14, 1998
The role of MDR-1 in refractory lymphoma
V Sandor, W Wilson, T Fojo, et al.
Archives of Biochemistry and Biophysics
|
July 15, 1983
Effects of acetylation and guanidination on alkaline conformations of chymotrypsin
A T Fojo, P L Whitney, W M Awad
Hospital Practice (Office Ed.)
|
April 15, 1990
Multidrug resistance due to P-glycoprotein
R K Burt, A T Fojo, S S Thorgeirsson
The Journal of Clinical Investigation
|
February 23, 2000
Pretreatment with DNA-damaging agents permits selective killing of checkpoint-deficient cells by microtubule-active drugs
M V Blagosklonny, R Robey, S Bates, et al.
Biochemical and Biophysical Research Communications
|
March 26, 1998
Like p53, the proliferation-associated protein p120 accumulates in human cancer cells following exposure to anticancer drugs
M V Blagosklonny, A Iglesias, Z Zhan, et al.
Oncogene
|
July 6, 2001
Low concentrations of paclitaxel induce cell type-dependent p53, p21 and G1/G2 arrest instead of mitotic arrest: molecular determinants of paclitaxel-induced cytotoxicity
P Giannakakou, R Robey, T Fojo, et al.
The Lancet. Respiratory Medicine
|
December 20, 2016
Expected effects of adopting a 9 month regimen for multidrug-resistant tuberculosis: a population modelling analysis
Emily A Kendall, Anthony T Fojo, David W Dowdy
Page
of 18
Search research articles
Search
Showing results (21-30 of 180) with videos related to
Sort By:
Page
of 18
The Journal of Clinical Endocrinology and Metabolism
|
February 7, 2001
Construction of gene therapy vectors targeting thyroid cells: enhancement of activity and specificity with histone deacetylase inhibitors and agents modulating the cyclic adenosine 3',5'-monophosphate pathway and demonstration of activity in follicular and anaplastic thyroid carcinoma cells
M Kitazono, Y Chuman, T Aikou, et al.
Current Drug Targets
|
May 12, 2004
Intractable cancers: the many faces of multidrug resistance and the many targets it presents for therapeutic attack
W D Stein, S E Bates, T Fojo
Japanese Journal of Cancer Research : Gann
|
September 27, 2001
Altered topoisomerase IIalpha and multidrug resistance-associated protein levels during drug selection: adaptations to increasing drug pressure
Y Matsumoto, H Takano, S Nagao, et al.
Leukemia & Lymphoma
|
March 14, 1998
The role of MDR-1 in refractory lymphoma
V Sandor, W Wilson, T Fojo, et al.
Archives of Biochemistry and Biophysics
|
July 15, 1983
Effects of acetylation and guanidination on alkaline conformations of chymotrypsin
A T Fojo, P L Whitney, W M Awad
Hospital Practice (Office Ed.)
|
April 15, 1990
Multidrug resistance due to P-glycoprotein
R K Burt, A T Fojo, S S Thorgeirsson
The Journal of Clinical Investigation
|
February 23, 2000
Pretreatment with DNA-damaging agents permits selective killing of checkpoint-deficient cells by microtubule-active drugs
M V Blagosklonny, R Robey, S Bates, et al.
Biochemical and Biophysical Research Communications
|
March 26, 1998
Like p53, the proliferation-associated protein p120 accumulates in human cancer cells following exposure to anticancer drugs
M V Blagosklonny, A Iglesias, Z Zhan, et al.
Oncogene
|
July 6, 2001
Low concentrations of paclitaxel induce cell type-dependent p53, p21 and G1/G2 arrest instead of mitotic arrest: molecular determinants of paclitaxel-induced cytotoxicity
P Giannakakou, R Robey, T Fojo, et al.
The Lancet. Respiratory Medicine
|
December 20, 2016
Expected effects of adopting a 9 month regimen for multidrug-resistant tuberculosis: a population modelling analysis
Emily A Kendall, Anthony T Fojo, David W Dowdy
Page
of 18